Significant Ownership of TCG Crossover GP II, LLC

Signature - Title
/s/ Craig Skaling - Craig Skaling, Authorized Signatory
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TCG Crossover GP II, LLC.

Follow Filing Activity

Follow TCG Crossover GP II, LLC and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of TCG Crossover GP II, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SRZN Surrozen, Inc. Common Stock, par value $0.0001 per share 11% $27,454,916 1,274,010 Chen Yu 26 Jan 2026
VOR Vor Biopharma Inc. Common Stock, par value $0.0001 per share 10% $8,623,079 5,673,078 Chen Yu 30 Mar 2026
TNGX Tango Therapeutics, Inc. Common Stock, par value $0.001 per share 10% $158,881,608 +$58,581,305 13,521,839 +58% TCG Crossover GP II, L.P. 31 Dec 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 10% $11,478,006 13,193,110 TCG Crossover GP II, LLC 27 Dec 2024
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $15,978,987 17,754,430 Chen Yu 09 Jan 2026
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 9.9% $14,703,389 13,011,849 Chen Yu 30 Jan 2026
ADCT ADC Therapeutics SA Common Shares, par value CHF $0.08 per share 9.2% $42,143,648 11,390,175 TCG Crossover GP II, LLC 27 Oct 2025
ALEC Alector, Inc. Common Stock, par value $0.0001 per share 9.2% $29,600,000 10,000,000 Chen Yu 22 Oct 2025
ADVM Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share 8.9% 1,871,482 TCG Crossover GP II, LLC 31 Mar 2025
LB Pharmaceuticals Inc. Common Stock, par value $0.0001 per share 7.8% 1,745,015 TCG Crossover GP II, LLC 12 Sep 2025
GLUE Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.2% $32,812,836 4,427,705 Chen Yu 10 Oct 2025
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 6.9% $21,767,809 7,915,567 Chen Yu 03 Feb 2026
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 6.2% $24,202,334 1,169,760 Chen Yu 12 Feb 2026
AMLX Amylyx Pharmaceuticals Inc. Common Stock, $0.0001 par value per share 5.7% $74,863,306 6,243,812 TCG Crossover GP II, LLC 31 Dec 2025
DNTH Dianthus Therapeutics, Inc. Common Stock, par value $0.001 per share 4.7% $32,660,322 1,501,624 TCG Crossover GP II, LLC 31 Mar 2025
EYPT Eyepoint, Inc. Common Stock, $0.001 par value per share 4.3% $62,265,799 3,572,335 TCG Crossover GP II, LLC 31 Dec 2025
NKTR Nektar Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$110,015,928 0 -100% TCG Crossover GP II, LLC 30 Sep 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 0 TCG Crossover GP II, LLC 30 Sep 2025

Schedules 13D/G Reported by TCG Crossover GP II, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored